Electrospun fibers for the treatment of skin diseases

Research output: Contribution to journalReviewResearchpeer-review

Standard

Electrospun fibers for the treatment of skin diseases. / Gürtler, Anna-Lena; Rades, Thomas; Heinz, Andrea.

In: Journal of controlled release : official journal of the Controlled Release Society, Vol. 363, 2023, p. 621-640.

Research output: Contribution to journalReviewResearchpeer-review

Harvard

Gürtler, A-L, Rades, T & Heinz, A 2023, 'Electrospun fibers for the treatment of skin diseases', Journal of controlled release : official journal of the Controlled Release Society, vol. 363, pp. 621-640. https://doi.org/10.1016/j.jconrel.2023.10.009

APA

Gürtler, A-L., Rades, T., & Heinz, A. (2023). Electrospun fibers for the treatment of skin diseases. Journal of controlled release : official journal of the Controlled Release Society, 363, 621-640. https://doi.org/10.1016/j.jconrel.2023.10.009

Vancouver

Gürtler A-L, Rades T, Heinz A. Electrospun fibers for the treatment of skin diseases. Journal of controlled release : official journal of the Controlled Release Society. 2023;363:621-640. https://doi.org/10.1016/j.jconrel.2023.10.009

Author

Gürtler, Anna-Lena ; Rades, Thomas ; Heinz, Andrea. / Electrospun fibers for the treatment of skin diseases. In: Journal of controlled release : official journal of the Controlled Release Society. 2023 ; Vol. 363. pp. 621-640.

Bibtex

@article{e2120280d58e400a876ccfaec93d1f9e,
title = "Electrospun fibers for the treatment of skin diseases",
abstract = "Skin diseases are among the most common diseases in the global population and with the growth of the aging population, they represent an increasing burden to healthcare systems worldwide. Even though they are rarely life-threatening, the suffering for those affected is high due to the visibility and physical discomfort related to these diseases. Typical symptoms of skin diseases include an inflamed, swollen or itchy skin, and therefore, there is a high demand for effective therapy options. In recent years, electrospinning has attracted considerable interest in the field of drug delivery. The technique allows producing multifunctional drug-loaded fibrous patches from various natural and synthetic polymers with fiber diameters in the nano- and micrometer range, suitable for the treatment of a wide variety of skin diseases. The great potential of electrospun fiber patches not only lies in their tunable drug release properties and the possibility to entrap a variety of therapeutic compounds, but they also provide physical and mechanical protection to the impaired skin area, exhibit a high surface area, allow gas exchange, absorb exudate due to their porous structure and are cytocompatible and biodegradable. In the case of wound healing, cell adhesion is promoted due to the resemblance of the electrospun fibers to the structure of the native extracellular matrix. This review gives an overview of the potential applications of electrospun fibers in skin therapy. In addition to the treatment of bacterial, diabetic and burn wounds, focus is placed on inflammatory diseases such as atopic dermatitis and psoriasis, and therapeutic options for the treatment of skin cancer, acne vulgaris and herpes labialis are discussed. While we aim to emphasize the great potential of electrospun fiber patches for the treatment of skin diseases with this review paper, we also highlight challenges and limitations of current research in the field.",
author = "Anna-Lena G{\"u}rtler and Thomas Rades and Andrea Heinz",
note = "Copyright {\textcopyright} 2023 The Author(s). Published by Elsevier B.V. All rights reserved.",
year = "2023",
doi = "10.1016/j.jconrel.2023.10.009",
language = "English",
volume = "363",
pages = "621--640",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Electrospun fibers for the treatment of skin diseases

AU - Gürtler, Anna-Lena

AU - Rades, Thomas

AU - Heinz, Andrea

N1 - Copyright © 2023 The Author(s). Published by Elsevier B.V. All rights reserved.

PY - 2023

Y1 - 2023

N2 - Skin diseases are among the most common diseases in the global population and with the growth of the aging population, they represent an increasing burden to healthcare systems worldwide. Even though they are rarely life-threatening, the suffering for those affected is high due to the visibility and physical discomfort related to these diseases. Typical symptoms of skin diseases include an inflamed, swollen or itchy skin, and therefore, there is a high demand for effective therapy options. In recent years, electrospinning has attracted considerable interest in the field of drug delivery. The technique allows producing multifunctional drug-loaded fibrous patches from various natural and synthetic polymers with fiber diameters in the nano- and micrometer range, suitable for the treatment of a wide variety of skin diseases. The great potential of electrospun fiber patches not only lies in their tunable drug release properties and the possibility to entrap a variety of therapeutic compounds, but they also provide physical and mechanical protection to the impaired skin area, exhibit a high surface area, allow gas exchange, absorb exudate due to their porous structure and are cytocompatible and biodegradable. In the case of wound healing, cell adhesion is promoted due to the resemblance of the electrospun fibers to the structure of the native extracellular matrix. This review gives an overview of the potential applications of electrospun fibers in skin therapy. In addition to the treatment of bacterial, diabetic and burn wounds, focus is placed on inflammatory diseases such as atopic dermatitis and psoriasis, and therapeutic options for the treatment of skin cancer, acne vulgaris and herpes labialis are discussed. While we aim to emphasize the great potential of electrospun fiber patches for the treatment of skin diseases with this review paper, we also highlight challenges and limitations of current research in the field.

AB - Skin diseases are among the most common diseases in the global population and with the growth of the aging population, they represent an increasing burden to healthcare systems worldwide. Even though they are rarely life-threatening, the suffering for those affected is high due to the visibility and physical discomfort related to these diseases. Typical symptoms of skin diseases include an inflamed, swollen or itchy skin, and therefore, there is a high demand for effective therapy options. In recent years, electrospinning has attracted considerable interest in the field of drug delivery. The technique allows producing multifunctional drug-loaded fibrous patches from various natural and synthetic polymers with fiber diameters in the nano- and micrometer range, suitable for the treatment of a wide variety of skin diseases. The great potential of electrospun fiber patches not only lies in their tunable drug release properties and the possibility to entrap a variety of therapeutic compounds, but they also provide physical and mechanical protection to the impaired skin area, exhibit a high surface area, allow gas exchange, absorb exudate due to their porous structure and are cytocompatible and biodegradable. In the case of wound healing, cell adhesion is promoted due to the resemblance of the electrospun fibers to the structure of the native extracellular matrix. This review gives an overview of the potential applications of electrospun fibers in skin therapy. In addition to the treatment of bacterial, diabetic and burn wounds, focus is placed on inflammatory diseases such as atopic dermatitis and psoriasis, and therapeutic options for the treatment of skin cancer, acne vulgaris and herpes labialis are discussed. While we aim to emphasize the great potential of electrospun fiber patches for the treatment of skin diseases with this review paper, we also highlight challenges and limitations of current research in the field.

U2 - 10.1016/j.jconrel.2023.10.009

DO - 10.1016/j.jconrel.2023.10.009

M3 - Review

C2 - 37820983

VL - 363

SP - 621

EP - 640

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

ER -

ID: 370571381